| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.3 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |